Last edition
News about "oral treatment "
Insmed's Brinsupri Wins Japan Approval for Non-Cystic Fibrosis Bronchiectasis
Insmed’s Brinsupri (brensocatib) has secured MHLW approval in Japan for non-cystic fibrosis bronchiectasis, expanding access to a new treatment option for patients with the chronic and progressive lung disease.
Oral Treatment | 26/08/2026 | By News Bureau
Edenbridge Pharmaceuticals Picks PANTHERx Rare for Distribution of Yargesa
PANTHERx Rare has been chosen by Edenbridge Pharmaceuticals for the distribution of Yargesa (miglustat) capsules.
Oral Treatment | 02/04/2024 | By Aishwarya | 552
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy